The early-stage startup-focused investment firm The Ventures has invested in the new drug development startup 'Pnasier,' which has been selected as a fast-track company for the Ministry of SMEs and Startups' private investment-led technology startup support program 'Deep Tech TIPS.'

The Ventures Early Investment 'Pnasier' Selected for Ministry of SMEs and Startups Deep Tech TIPS View original image

According to The Ventures on the 29th, Pnasier was recognized for its excellent technology during the first evaluation of Deep Tech TIPS by the Ministry of SMEs and Startups and passed the fast-track, exempting it from the second marketability evaluation. Deep Tech TIPS is a program that supports promising startups with outstanding technology in 10 new industry sectors by providing up to 1.7 billion KRW over three years for technology development, startup commercialization, and overseas marketing.


Founded last year, Pnasier possesses a one-step drug delivery system (DDS) as its core technology. A representative from The Ventures emphasized, "Pnasier's drug delivery system technology has strengths such as fast production time, high cost efficiency, stability in drug storage, and versatility in applying APIs."


Through this program selection, Pnasier plans to strengthen research and development to further specify its goal of transferring drug delivery technology to global pharmaceutical companies and to attract funding from overseas and domestic investors at the pre-Series A stage.


Shin Hyun-woo, CEO of Pnasier, stated, "We are pleased to be recognized as a deep tech company and selected for the fast-track. We will focus on developing more advanced technology based on the 'one-step drug delivery technology.'"



Kim Cheol-woo, CEO of The Ventures, said, "Both startups supported by The Ventures for Deep Tech TIPS selection this year have been chosen. Through this Deep Tech TIPS selection, we will continue to support Pnasier in advancing its drug delivery system technology and expanding its business through collaboration with global pharmaceutical companies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing